Horizon Discovery Ltd

Type: Company
Name: Horizon Discovery Ltd
First reported Apr 21 2014 - Updated Apr 21 2014 - 1 reports

Cambridge Index rises 1.2%

The Cambridge Index gained 1.2% or 205.95 points to 17,014.4, as seven out of the top ten index heavyweights managed to record weekly gains. Credit Suisse restated its “Outperform” rating on the shares of ARM Holdings, up 1.9%, along with a target price ... [Published NW Brown Group Limited - Apr 21 2014]
First reported Apr 21 2014 - Updated Apr 21 2014 - 1 reports

Horizon Discovery launches new GENASSIST gene editing tools and services

Horizon Discovery Group plc, a life science company, has launched a range of GENASSIST gene editing kits, reagents and support services that enable implementation of gene editing experiments with CRISPR and rAAV. GENASSIST offers a broad range of thoroughly ... [Published Individual.com - Apr 21 2014]
First reported Apr 07 2014 - Updated Apr 08 2014 - 4 reports

Horizon Discovery launches new Genassist CRISPR and rAAV gene editing tools and services

Horizon Discovery has announced the launch of its full range of Genassist gene editing kits, reagents and support services that enable easier, robust implementation of gene editing experiments with CRISPR and rAAV. ... [Published PBR - News - Apr 08 2014]
First reported Apr 04 2014 - Updated Apr 04 2014 - 1 reports

Sweet charity from Horizon shows the caring side of business

Up to his eyes in a round of pre-IPO meetings with investors just a week ahead of an AIM float, Horizon Discovery CEO Darrin Disley found time to put charity ahead of commercial considerations. ... [Published Business Weekly UK - Apr 04 2014]
First reported Apr 03 2014 - Updated Apr 03 2014 - 1 reports

Recruitment drive in full swing at Horizon Discovery

CEO Darrin Disley says staff morale is running at “an all-time high” at Horizon Discovery following the rollout of the biotech company’s post-IPO incentive plans and roadmap for expansion.Dr Disley said that a week on from the highly successful AIM IPO ... [Published Business Weekly UK - Apr 03 2014]
First reported Apr 01 2014 - Updated Apr 01 2014 - 1 reports

PANMURE GORDON : leads IPO for Horizon Discovery Group...

Panmure Gordon & Co, a leading independent institutional stockbroker and investment bank, is pleased to advise that it has acted as Nominated Adviser and sole broker on the IPO of Horizon Discovery Group plc (HZD.L) raising £68.6m.Horizon Discovery Group ... [Published 4 Traders - Apr 01 2014]
First reported Mar 27 2014 - Updated Mar 27 2014 - 2 reports

Horizon Discovery Group plc Raises £68.6 million

Pioneer of Translational Genomics to be admitted to AIM with a Market Capitalisation of £120.5 millionHorizon Discovery Group plc ("Horizon" or "the Company"), the revenue generating life science company supplying research tools to organisations engaged ... [Published FierceBiotech - Mar 27 2014]
First reported Mar 27 2014 - Updated Mar 27 2014 - 6 reports

Horizon advised by Consilium on AIM Listing

Consilium Strategic Communications advised on the successful IPO of Horizon Discovery which listed on the AIM market of the London Stock Exchange today.Horizon Discovery is a revenue generating, leading life science company supplying research tools to ... [Published GorkanaPR - Mar 27 2014]
First reported Mar 27 2014 - Updated Mar 27 2014 - 2 reports

Consilium Strategic Communications advises on Horizon Discovery IPO

Horizon Discovery, a medical research company, was advised on its £68.6m IPO on AIM today by Consillium Strategic Communications.Consillium's team, comprising Amber Bielecka, Mary-Jane Elliott, Jessica Hodgson, Matthew Neal and Melissa Jumbo, will continue ... [Published PR Week UK - Mar 27 2014]
First reported Mar 25 2014 - Updated Mar 25 2014 - 1 reports

Horizon Discovery IPO over-subscribed

Horizon Discovery Group Plc has raised £68.6 million with an initial public offering on the London Stock Exchange’s Alternative Investment Market, well in excess of the originally targeted £25 million. Horizon will use the funds to expand the sales of ... [Published MedNous - Mar 25 2014]
First reported Mar 24 2014 - Updated Mar 24 2014 - 5 reports

£120.5m valuation will make Horizon Discovery Cambridge's second largest listed biotech

SH404SEF : headers were already sent when I got control!This is not necessarily a sh404sef error. It may have been caused by any of your extensions or even Joomla itself. If there is no error message above this one, providing more details, then you may ... [Published Cabume - Mar 24 2014]
First reported Mar 24 2014 - Updated Mar 24 2014 - 4 reports

Horizon Discovery Group plc raises £68.6 million

Horizon Discovery Group plc, the revenue generating life science company supplying research tools to organisations engaged in genomics research and the development of personalised medicines, is to be admitted to AIM with a market capitalisation of £120.5 ... [Published Cambridge Network - Mar 24 2014]

Quotes

Dr Darrin M Disley, CEO, Horizon Discovery, commented: "Horizon's goal is to make the latest developments in gene editing accessible to the wider scientific audience. As the only company which can offer both nuclease techniques in the form of CRISPR or ZFN and homologous recombination harnessing rAAV, we are ensuring that researchers can make an informed choice of which technology or combination of technologies is best in order to gain the answer to the biological question being asked."
Alison Dennis , a Partner at Field Fisher Waterhouse and head of Life Sciences and Healthcare, commented: "Field Fisher Waterhouse is delighted to sponsor OBN which has shown itself to be a cornerstone of the UK life sciences sector, focusing on activities that give emerging R&D companies a competitive edge in the fundraising and deal-making arenas. We are pleased to formalise our support of OBN's work and will be lending our support to two OBN Senior Executive Dinners this year, the first in Cambridge on 3 June, the second in London later in the year. These invitation-only events will provide company decision-makers with that all-important, closed environment to network with their peers."
"Horizon's success has been driven by the way we partner with our customers. By offering access to our gene editing expertise we give researchers the best chance of success in their gene editing projects, said Eric Rhodes, VP of R&D and Chief Technology Officer, Horizon Discovery. "Our new GENASSIST range of tools and services, combined with access to rAAV, ZFN, and CRISPR technologies, gives researchers an invaluable resource to determine the function of endogenous gene alterations and their effect on disease and therapeutic responses."
...6 million of Sale Shares, at a price of 180p per share.  Dr Darrin M Disley, Chief Executive Officer of Horizon Discovery Group plc, commented: "Our listing today and the funds raised will fuel Horizon Discovery's ambition to become the global leader in the provision of Life Science research tools that enable the understanding of the genetic basis of disease and the development of personalised medicines."

More Content

All (108) | News (74) | Reports (0) | Blogs (32) | Audio/Video (1) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Cambridge Index rises 1.2% [Published NW Brown Group Limited - Apr 21 2014]
Horizon Discovery launches new GENASSIST gene e... [Published Individual.com - Apr 21 2014]
Field Fisher Waterhouse Becomes OBN Corporate S... [Published Michigan Live - Apr 17 2014]
Cambridge Index falls 3.3% [Published NW Brown Group Limited - Apr 14 2014]
Concepta secures GBP2.3m equity investment [Published Private Equity Wire - Apr 14 2014]
Horizon Dis Grp Ltd : Employee SAYE Share Plan [Published Investegate - Apr 11 2014]
‘Candy Crush’ Maker King Digital Helps European... [Published WSJ.com: Venture Capital Dispatch - Apr 09 2014]
Horizon Discovery launches new Genassist CRISPR... [Published Big News Network - Apr 08 2014]
Horizon Discovery launches new Genassist CRISPR... [Published PBR - News - Apr 08 2014]
Australia’s Starpharma extends deal with AstraZ... [Published Invezz - Apr 07 2014]
Cambridge Index rises 0.8% [Published NW Brown Group Limited - Apr 07 2014]
Covington & Burling advises life sciences compa... [Published The Lawyer - Apr 07 2014]
Horizon opens up a new world of research capabi... [Published Business Weekly UK - Apr 07 2014]
HORIZON DISCOVERY : Launches New GENASSIST CRIS... [Published 4 Traders - Apr 07 2014]
Horizon Discovery Launches New GENASSIST CRISPR... [Published Noodls - Apr 07 2014]
UK can be the world's digital capital if tech s... [Published Telegraph - Apr 06 2014]
Sweet charity from Horizon shows the caring sid... [Published Business Weekly UK - Apr 04 2014]
Recruitment drive in full swing at Horizon Disc... [Published Business Weekly UK - Apr 03 2014]
Horizon Discovery : 2014 American Association o... [Published 4 Traders - Apr 03 2014]
ebusiness weekly news 03/04 /2014 [Published Biz East - Apr 03 2014]
Cambridge deals top $27.5bn in first year of bu... [Published Business Weekly UK - Apr 02 2014]
Balderton Capital raises $305m to fund next gen... [Published Tech City News - Apr 01 2014]
DFJ Esprit launches EIS fund [Published Private Equity Wire - Apr 01 2014]
PANMURE GORDON : leads IPO for Horizon Discover... [Published 4 Traders - Apr 01 2014]
AstraZeneca to build drug discovery centre in C... [Published Invezz - Mar 31 2014]
Announcement: Horizon Discovery is Business Wee... [Published Noodls - Mar 31 2014]
Horizon Discovery Group plc Announces Intention... [Published Noodls - Mar 31 2014]
£120.5m valuation will make Horizon Discovery C... [Published Noodls - Mar 31 2014]
News Nuggets: 24-28 March, 2014 [Published Lex100 - Mar 28 2014]
Biotech booms as Horizon Discovery secures £69m... [Published Tech City News - Mar 28 2014]
1 2 3 4
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
‘Candy Crush’ Maker King Digital Helps European... [Published WSJ.com: Venture Capital Dispatch - Apr 09 2014]
King Digital Entertainment Plc, the maker of the popular mobile game “Candy Crush,” helped bring the money raised from initial public offerings by Europe-based companies in the first quarter to a level not seen since 2000. King Digital Entertainment ...
Horizon Discovery launches new Genassist CRISPR... [Published PBR - News - Apr 08 2014]
Horizon Discovery has announced the launch of its full range of Genassist gene editing kits, reagents and support services that enable easier, robust implementation of gene editing experiments with CRISPR and rAAV. ...
Horizon Discovery Signs Supply and Distribution... [Published EON Science - Feb 17 2014]
CAMBRIDGE, England--(EON: Enhanced Online News)--Horizon Discovery signed a supply & distribution agreement with Sirion Biotech, for RNAiONE custom shRNA development services, and off-the-shelf validated shRNA and cDNA over-expression reagents. ...
Horizon Discovery Signs Supply and Distribution... [Published Business Wire Science: Science News - Feb 17 2014]
CAMBRIDGE, England--(BUSINESS WIRE)--Horizon Discovery signed a supply & distribution agreement with Sirion Biotech, for RNAiONE custom shRNA development services, and off-the-shelf validated shRNA and cDNA over-expression reagents. ...
Horizon Discovery Signs Supply and Distribution... [Published Business Wire Health News - Feb 17 2014]
CAMBRIDGE, England--(BUSINESS WIRE)--Horizon Discovery signed a supply & distribution agreement with Sirion Biotech, for RNAiONE custom shRNA development services, and off-the-shelf validated shRNA and cDNA over-expression reagents. ...
1 2 3 4 5 6 7

Audio/Video

sort by: Date | Relevance
THE GHOST IN YOUR GENES: HORIZON - Discovery/Hi... [Published Mefeedia Video Tag : geneti - Jan 12 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.